Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Robbins Arroyo LLP: Immunomedics, Inc. (IMMU) Misled Shareholders According to a Recently Filed Class Action

IMMUNOMEDICS (IMMU)  More Company Research Source: Business Wire
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF SAN DIEGO & MORRIS PLAINS, N.J.--(BUSINESS WIRE)-- Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Immunomedics, Inc. (NASDAQGM: IMMU) filed a class action complaint against the company for alleged violations of the Securities and Exchange Act of 1934 between August 23, 2018 and December 20, 2018. Immunomedics, a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer. View this information on the law firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/immunomedics-inc-jan-2019/ Immunomedics Accused of Data Integrity Breach According to the complaint, on December 17, 2018, FDAnews.com published an article, stating that "[t]he FDA cited Immunomedics for a host of violations – including its handling of a data integrity breach – observed at its Morris Plains, New Jersey, d [Read more]
Impact snapshot Event time: IMMU
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
IMMU alerts
from News Quantified
Opt-in for
IMMU alerts

from News Quantified
Opt-in for
IMMU alerts

from News Quantified